Diverting a Diet Drug

Diverting a Diet Drug How did a controversial product become the first weight-loss drug to be available without a prescription? By Fran Hawthorne Illustrations by Bill Sanderson Related Articles 1 "That was another big Aha! moment, because we didn't know that study existed," Burton says. The researchers found that people who took orlistat (the generic name for Xenical) experienced a 37% lower risk of type 2 diabetes. According to the report, "the overal

| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

By Fran Hawthorne
Illustrations by Bill Sanderson

1 "That was another big Aha! moment, because we didn't know that study existed," Burton says.

The researchers found that people who took orlistat (the generic name for Xenical) experienced a 37% lower risk of type 2 diabetes. According to the report, "the overall incidence of adverse events was similar" in the control group and the group on orlistat, although more people on orlistat experienced "mild to moderate" gastrointestinal events. (The incidence decreased as people stayed longer on the drug.) Along with the more common side effects, Xenical can interfere with the absorption of many drugs such as warfarin and cyclosporine, as well as fat-soluble vitamins. Rarely, it's been linked to acute kidney injury and liver problems. 2

The GSK team left the Marriott meeting eager to move ahead. But the ball was in Roche's court. And Roche wasn't sure it wanted to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Bill Sanderson

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide